Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|September 12, 2006
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosisP Prandoni, A Ghirarduzzi, M H Prins, et al.
Thrombosis Research|November 23, 2018
Lupus anticoagulant identifies two distinct groups of patients with different antibody patternsV Pengo, T Del Ross, A Ruffatti, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus|December 17, 2008
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?Z Rotar, B Rozman, P G de Groot, et al.
Lupus|February 10, 2011
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010S S Pierangeli, P G de Groot, J Dlott, et al.
Thrombosis Research|June 15, 2010
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)V Pengo, G Denas, E Bison, et al.
The Pharmacogenomics Journal|August 10, 2016
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithmsK Kubo, M Ohara, M Tachikawa, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter studyB de Laat, V Pengo, I Pabinger, et al.
Lupus|September 17, 2013
Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)N Agmon-Levin, C Rosário, B-S Porat Katz, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|September 12, 2006
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosisP Prandoni, A Ghirarduzzi, M H Prins, et al.
Thrombosis Research|November 23, 2018
Lupus anticoagulant identifies two distinct groups of patients with different antibody patternsV Pengo, T Del Ross, A Ruffatti, et al.
Lupus|February 10, 2011
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodiesG Ruiz-Irastorza, M J Cuadrado, I Ruiz-Arruza, et al.
Lupus|December 17, 2008
Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?Z Rotar, B Rozman, P G de Groot, et al.
Lupus|February 10, 2011
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010S S Pierangeli, P G de Groot, J Dlott, et al.
Thrombosis Research|June 15, 2010
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)V Pengo, G Denas, E Bison, et al.
The Pharmacogenomics Journal|August 10, 2016
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithmsK Kubo, M Ohara, M Tachikawa, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter studyB de Laat, V Pengo, I Pabinger, et al.
Lupus|September 17, 2013
Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)N Agmon-Levin, C Rosário, B-S Porat Katz, et al.
Pageof 17